The Signature, Derived From a Liquid Biopsy Test, has the Potential to Avoid the Complications of Repeated Needle Biopsies ROTTERDAM, Netherlands–(BUSINESS WIRE)–Exosome Diagnostics, a developer of revolutionary biofluid-based molecular diagnostics, in collaboration with Brigham and Women’s Hospital, in Boston, Mass., ...
Read More »
from Oncology Nurse Advisor by Kathy Boltz, PhD Analyzing tumor DNA fragments in the bloodstream, known as circulating tumor DNA (ctDNA), may offer a more complete view of a patient’s cancer from a molecular perspective. These findings were published in ...
Read More »
from Nature Reviews Genetics by Liesbet Lieben A systemic, minimally invasive diagnostic test to determine whether an individual has cancer could greatly improve cancer prognosis by facilitating early diagnosis and improving monitoring. However, the use of blood-based ‘liquid biopsies’ is ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
